Literature DB >> 9730292

Moraxella catarrhalis bacteraemia. A report on 3 cases and a review of the literature.

B Thórsson1, V Haraldsdóttir, M Kristjánsson.   

Abstract

Over the last decade, an increase in invasive infections due to Moraxella catarrhalis has been reported. We have analysed 58 cases of bacteraemia due to M. catarrhalis reported in the literature and 3 cases found in Iceland, a total of 61 cases. Patients with bacteraemia could be divided into 3 groups on the basis of host factors. They were either immunocompromised, had underlying respiratory disorders. or were normal hosts. The clinical manifestation of M. catarrhalis bacteraemic infection ranged from a mild febrile illness to a fatal disease. The severity of the clinical picture did not reflect the patients' condition at the time of bacteraemia. The port of entry of the bacteraemia was frequently not elucidated in immunocompromised patients. Patients with a contributory respiratory tract disorder were more likely to develop bacteraemia as a result of a lower respiratory tract infection, whereas bacteraemia in a normal host was more frequently due to an upper respiratory tract infection. The overall prognosis of M. catarrhalis bacteraemia was good, the exception being when it caused endocarditis (5 cases), where mortality rates as high as 80% have been reported.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9730292     DOI: 10.1080/003655498750003447

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  11 in total

1.  Infectious endocarditis and vertebral osteomyelitis caused by Moraxella catarrhalis.

Authors:  Serban M Maierean; Daniel C Marinescu; David O Croitoru; Amol A Verma
Journal:  BMJ Case Rep       Date:  2019-05-24

2.  Pulmonary thin-section CT findings in acute Moraxella catarrhalis pulmonary infection.

Authors:  F Okada; Y Ando; T Nakayama; S Tanoue; R Ishii; A Ono; M Watanabe; H Takaki; T Maeda; H Mori
Journal:  Br J Radiol       Date:  2010-12-01       Impact factor: 3.039

Review 3.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  Hag mediates adherence of Moraxella catarrhalis to ciliated human airway cells.

Authors:  Rachel Balder; Thomas M Krunkosky; Chi Q Nguyen; Lacey Feezel; Eric R Lafontaine
Journal:  Infect Immun       Date:  2009-08-10       Impact factor: 3.441

5.  Moraxella catarrhalis bacteraemia and prosthetic valve endocarditis.

Authors:  Lokesh Shahani; Shahriar Tavakoli Tabasi
Journal:  BMJ Case Rep       Date:  2015-10-23

6.  The Hag protein of Moraxella catarrhalis strain O35E is associated with adherence to human lung and middle ear cells.

Authors:  Melissa M Holm; Serena L Vanlerberg; Darren D Sledjeski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

7.  Large unilateral pleural effusion secondary to Moraxella catarrhalis infection.

Authors:  Kushal Naha; Ravindra Prabhu
Journal:  Australas Med J       Date:  2011-09-30

8.  The Moraxella catarrhalis porin-like outer membrane protein CD is an adhesin for human lung cells.

Authors:  Melissa M Holm; Serena L Vanlerberg; Ian M Foley; Darren D Sledjeski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

9.  Community-Acquired Moraxella catarrhalis Bacteremic Pneumonia: Two Case Reports and Review of the Literature.

Authors:  Miguel Angel Ariza-Prota; Ana Pando-Sandoval; Marta García-Clemente; David Fole-Vázquez; Pere Casan
Journal:  Case Rep Pulmonol       Date:  2016-02-18

10.  Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.

Authors:  Teresa L Shaffer; Rachel Balder; Sean W Buskirk; Robert J Hogan; Eric R Lafontaine
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.